AI-Enabled Biotech Drug Discovery Market - Strategic Insights and Forecasts (2026-2031)

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

1. 2.1. Market Overview

2. 2.2. Market Definition

3. 2.3. Scope of the Study

4. 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

1. 3.1. Market Drivers

2. 3.2. Market Restraints

3. 3.3. Market Opportunities

4. 3.4. Porter’s Five Forces Analysis

5. 3.5. Industry Value Chain Analysis

6. 3.6. Policies and Regulations

7. 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AI-ENABLED BIOTECH DRUG DISCOVERY MARKET BY COMPONENT

1. 5.1. Introduction

2. 5.2. Software Platforms

3. 5.3. Services

6. AI-ENABLED BIOTECH DRUG DISCOVERY MARKET BY TECHNOLOGY

1. 6.1. Introduction

2. 6.2. Machine Learning

3. 6.3. Deep Learning

4. 6.4. Natural Language Processing (NLP)

5. 6.5. Computer Vision

6. 6.6. Others

7. AI-ENABLED BIOTECH DRUG DISCOVERY MARKET BY APPLICATION

1. 7.1. Introduction

2. 7.2. Target Identification

3. 7.3. Lead Generation & Optimization

4. 7.4. Drug Screening

5. 7.5. Preclinical Testing

6. 7.6. Clinical Trials

8. AI-ENABLED BIOTECH DRUG DISCOVERY MARKET BY GEOGRAPHY

1. 8.1. Introduction

2. 8.2. North America

   1. 8.2.1. USA

   2. 8.2.2. Canada

   3. 8.2.3. Mexico

3. 8.3. South America

   1. 8.3.1. Brazil

   2. 8.3.2. Argentina

   3. 8.3.3. Others

4. 8.4. Europe

   1. 8.4.1. United Kingdom

   2. 8.4.2. Germany

   3. 8.4.3. France

   4. 8.4.4. Spain

   5. 8.4.5. Others

5. 8.5. Middle East and Africa

   1. 8.5.1. Saudi Arabia

   2. 8.5.2. UAE

   3. 8.5.3. Others

6. 8.6. Asia Pacific

   1. 8.6.1. China

   2. 8.6.2. India

   3. 8.6.3. Japan

   4. 8.6.4. South Korea

   5. 8.6.5. Indonesia

   6. 8.6.6. Thailand

   7. 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

1. 9.1. Major Players and Strategy Analysis

2. 9.2. Market Share Analysis

3. 9.3. Mergers, Acquisitions, Agreements, and Collaborations

4. 9.4. Competitive Dashboard

10. COMPANY PROFILES

1. 10.1. Insilico Medicine

2. 10.2. Atomwise

3. 10.3. BenevolentAI

4. 10.4. Insitro

5. 10.5. Generate Biomedicines

6. 10.6. Recursion Pharmaceuticals

7. 10.7. AbCellera Biologics

8. 10.8. Owkin

9. 10.9. XtalPi

10. 10.10. Isomorphic Labs

11. 10.11. SOM Biotech

11. APPENDIX

1. 11.1. Currency

2. 11.2. Assumptions

3. 11.3. Base and Forecast Years Timeline

4. 11.4. Key benefits for the stakeholders

5. 11.5. Research Methodology

6. 11.6. Abbreviations